Table 1

Demographic characteristics and prevalence of metabolic disorders

Characteristics (%)

Men (n = 2092)

Death

Women (n = 2197)

Death

p-valuec


All-cause (n = 167)

CVD (n = 42)

All-cause (n = 91)

CVD (n = 32)


Age (yrs.)

0.0001


30-45

920 (44.0)

16 (9.6)

6 (14.3)

1054 (48.0)

13 (14.3)

1 (3.1)

45-55

533 (25.5)

28 (16.8)

5 (11.9)

598 (27.2)

15 (16.5)

3 (9.4)

≥ 55

639 (30.5)

123 (73.7)

31 (73.8)

545 (24.8)

63 (69.2)

28 (87.5)


BMIa (kg/m²)

< 0.0001


< 18.5

56 (2.7)

10 (6.0)

1 (2.7)

125 (5.7)

9 (9.9)

3 (10.3)

18.5-24.9

1273 (60.9)

107 (64.1)

25 (67.6)

1500 (68.3)

48 (52.8)

18 (62.1)

25-29.9 ≥

679 (32.5)

44 (26.4)

9 (24.3)

479 (21.8)

28 (30.8)

8 (27.6)

30

84 (4.0)

6 (3.6)

2 (5.4)

93 (4.2)

6 (6.6)

0 (0.0)


BMIb (kg/m²)

< 0.0001


< 18.5

56 (2.7)9

10 (6.0)

1 (2.4)

125 (5.7)

9 (9.9)

3 (9.4)

18.5-24

78 (46.8)

84 (50.3)

19 (45.2)

1279 (58.2)

39 (42.9)

16 (50.0)

24-27

708 (33.8)

57 (34.1)

15 (35.7)

528 (24.0)

25 (27.5)

9 (28.1)

≥ 27

350 (16.7)

16 (9.6)

7 (16.7)

265 (12.1)

18 (19.8)

4 (12.5)


Alcohol drinking

982 (46.9)

65 (38.9)

13 (31.0)

258 (11.7)

10 (11.0)

3 (9.4)

< 0.0001


Smoking

1116 (53.4)

104 (62.3)

24 (57.1)

85 (3.9)

9 (9.9)

3 (9.4)

< 0.0001


Betel nut chewing

660 (31.6)

57 (34.1)

16 (38.1)

61 (2.8)

5 (5.5)

2 (6.3)

< 0.0001


Excercise

1076 (51.4)

90 (53.9)

23 (54.8)

1204 (54.8)

42 (46.2)

12 (37.5)

0.03


Education

< 0.0001


Less than elementary school

550 (26.3)

94 (56.3)53 (31.7) 20 (12.0)

24 (57.1)13 (31.0)5 (11.9)

811 (37.0)996 (45.4)388 (17.7)

69 (75.8)19 (20.9) 3 (3.3)

27 (84.4) 5 (15.6) 0 (0.0)

High school diploma

996 (47.6)

More than high school

546 (26.1)


Marital status

< 0.0001


Married

1804 (86.3)

133 (79.6)

34 (81.0)1 (2.4)3 (7.1)4 (9.5)

1780 (81.0) 87 (4.0) 216 (9.8) 114 (5.2)

49 (53.9) 4 (4.4) 37 (40.7) 1 (1.1)

15 (46.9) 1 (3.1)16 (50.0) 0 (0.0)

Divorced or separated

54 (2.5)

4 (2.4)

Widower or widow/Living together Single

60 (2.8)

174 (8.4)

16 (9.6)

14 (8.4)


Income

< 0.0001


No income

228 (10.9)

44 (26.5)

10 (23.8)

760 (34.7)

47 (51.7)

19 (59.4)

Less than 10,000 NTD

197 (9.5)

33 (19.9)

9 (21.4)

263 (12.0)

27 (29.7)

12 (37.5)

10,000-40,000 NTD

888 (42.6)

63 (38.0)

18 (42.9)

886 (40.5)

14 (15.4)

1 (3.1)

More than 40,000 NTD

772 (37.0)

26 (15.7)

5 (11.9)

281 (12.8)

3 (3.3)

0 (0.0)


Self-reported CVD

277 (13.3)

47 (28.1)

19 (45.2)

290 (13.2)

36 (40.0)

18 (58.1)

0.9667


MetS

467 (22.3)

58 (34.7)

24 (57.1)

347 (15.8)

39 (42.9)

20 (62.5)

< 0.0001


High WC

702 (33.6)

64 (38.3)

21 (50.0)

742 (33.8)

56 (61.5)

25 (78.1)

0.88


AH

596 (28.5)

94 (56.3)

32 (76.2)

422 (19.2)

50 (55.0)

20 (62.5)

< 0.0001


DM

188 (9.0)

35 (21.0)

16 (38.1)

147 (6.7)

22 (24.2)

11 (34.4)


HighTG

464 (22.2)

35 (21.0)

13 (31.0)

241 (11.0)

20 (22.0)

11 (34.4)

< 0.0001


Low HDL-C

479 (22.9)

50 (29.9)

15 (35.7)

522 (23.8)

25 (27.5)

17 (53.1)

0.50


a: BMI classification according to the recommended standard of the WHO

b: BMI classification according to the recommended standard of the Taiwan

Department of Health

c: Significance level of two sample t-test or chi-squared test for the difference in gender

1BMI, body mass index; DM, diabetes mellitus; AH, arterial hypertension; HDL-C, high-density lipoprotein cholesterol; MetS, metabolic syndrome; NTD, New Taiwan Dollar; TG, triglycerides; WC, waist circumference

2Central obesity was defined as WC ≥ 90 cm in men and ≥ 80 cm in women; AH was defined as an average SBP of ≥ 140 mmHg, DBP of ≥ 90 mmHg, or treatment for previously diagnosed AH; DM was defined as a FPG ≥ 126 mg/dL (7 mmol/L) or use of insulin or other hypoglycemic agents; High TG was defined as a serum triacylglycerol concentration ≥ 200 mg/dL (2.26 mmol/L); Low HDL-C was defined as a HDL-C < 40 mg/dL (1.03 mmol/L) in men and < 50 mg/dL (1.29 mmol/L) in women; The (modified) NCEP MetS was defined as having at least three of the following: (1) WC ≥ 90 cm in men and ≥ 80 cm in women; (2) SBP ≥ 130 mmHg, DBP ≥ 85 mmHg, or self-reported treatment with antihypertensive medications; (3) FPG ≥ 110 mg/dL (6.1 mmol/L) or use of insulin or hypoglycemic agents; (4) serum TG ≥ 150 mg/dL (1.7 mmol/L); (5) low HDL-C

Wang et al. BMC Public Health 2012 12:111   doi:10.1186/1471-2458-12-111

Open Data